ARTICLE | Clinical News
Columbia regulatory update
June 19, 1995 7:00 AM UTC
Columbia Laboratories Inc. (COB) COB's Crinone natural progesterone received U.K. marketing approval to prevent hyperplasia and endometrial cancer in postmenopausal women receiving hormone replacemen...